Tuesday's Small-Cap Winners & Losers
Updated from 2:11 p.m. EDT
Layne Christensen (LAYN) shares were leaping Tuesday after the construction company more than doubled its fiscal fourth-quarter income year over year to $6.7 million, or 42 cents a share, on revenue that climbed 31.6% from last year to $193.1 million. Analysts polled by Thomson Financial were seeking 21 cents a share on $158.9 million in sales. Shares of the Kansas-based firm were up $2.81, or 7.6%, to $39.80.
Cell Genesys (CEGE) shares jumped after a midphase trial showed its Gvax prostate-cancer immunotherapy to induce a median survival rate of 35 months in about a quarter of the test population -- those patients receiving dosage similar to that being used in ongoing late-phase testing. A prior midphase trial's results had indicated 26.2-month median survival rate.
The California-based company noted that the current standard of care -- Taxotere chemotherapy plus prednisone -- yielded only 18.9-month median survival in published results. Shares rose $1.39, or 32.3%, to $5.70.New Jersey's J&J Snack Foods (JJSF), which makes Luigi's Italian Ices and licenses the Minute Maid brand name, gained after it bought Whole Food Sorbet and Fruit-A-Freeze Frozen Fruit Bar brands and related assets from CoolBrands International. Terms weren't disclosed. Shares were up 63 cents, or 1.6%, to $40.11. Iridex (IRIX), on the other hand, was plummeting some 20.9% after the medical-equipment maker swung to a fourth-quarter loss of $3.8 million, or 48 cents a share, compared with a nickel-a-share gain last year. Sales shed 13.3% year over year to $9 million, though this roughly meets two analysts' targets. The Mountain View, Calif., company also said its current liquidity and capital resources are likely insufficient for planned operations over the coming year. The company's auditors have accordingly expressed "substantial doubt as to
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV